Literature DB >> 6644569

In vivo and in vitro release of macromolecules from polymeric drug delivery systems.

L R Brown, C L Wei, R Langer.   

Abstract

In vivo release rates of a macromolecule from an ethylene-vinyl acetate copolymer have been shown to be indistinguishable from those of identical implants tested in vitro. The studies were conducted for approximately 2 months, and two different techniques were used to assess release rates. One of these techniques, using [3H]inulin as a marker, may be particularly useful in future studies assessing in vivo release rates from drug delivery systems. The appearance of [3H]inulin in the urine of rats bearing implants allowed continuous monitoring of release. A histological evaluation of tissue sections surrounding polymer implanted for 7 months showed no inflammatory cell reaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644569     DOI: 10.1002/jps.2600721019

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.

Authors:  D Bommannan; H Okuyama; P Stauffer; R H Guy
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

2.  The role of polymer matrix structure and interparticle interactions in diffusion-limited drug release.

Authors:  A C Balazs; D F Calef; J M Deutch; R A Siegel; R Langer
Journal:  Biophys J       Date:  1985-01       Impact factor: 4.033

3.  Enzymatically controlled drug delivery.

Authors:  F Fischel-Ghodsian; L Brown; E Mathiowitz; D Brandenburg; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Polymeric controlled-release amsacrine chemotherapy in an experimental glioma model.

Authors:  L U Wahlberg; P M Almqvist; M J Glantz; J Boëthius
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.

Authors:  I J Polakowski; M K Lewis; V R Muthukkaruppan; B Erdman; L Kubai; R Auerbach
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Release of human serum albumin from poly(lactide-co-glycolide) microspheres.

Authors:  M S Hora; R K Rana; J H Nunberg; T R Tice; R M Gilley; M E Hudson
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

7.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

Authors:  E R Edelman; D H Adams; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  A micro sustained release system for epidermal growth factor.

Authors:  J B Murray; L Brown; R Langer; M Klagsburn
Journal:  In Vitro       Date:  1983-10

9.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs.

Authors:  D Levy; J Kost; Y Meshulam; R Langer
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.

Authors:  Lawrence Kleinberg
Journal:  Core Evid       Date:  2012-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.